Portal de recerca
ESTUDIO ALEATORIZADO, CON DOBLE ENMASCARAMIENTO, DE INICIO DIFERIDO, EN EL QUE SE EVALÚA LY3314814 (AZD3293) EN LA ENFERMEDAD DE ALZHEIMER EN FASE TEMPRANA (AMPLIACIÓN DEL ESTUDIO AZES, EL ESTUDIO AMARANTH).
Dades bàsiques
- Protocol:
- I8D-MC-AZFD
- EURDRACT:
- 2016-003440-36
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2018
- Any de finalització:
- 2018
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
A cross-sectional and longitudinal study on the protective effect of bilingualism against dementia using brain atrophy and cognitive measures.
Costumero V; (...); Ávila C
Article. 10.1186/s13195-020-0581-1. 2020
A novel TRMT5 mutation causes a complex inherited neuropathy syndrome: the role of nerve pathology in defining a demyelinating neuropathy.
Argente-Escrig, Herminia; (...); Sevilla, Teresa
Article. 10.1111/nan.12817. 2022
A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging.
Muelas N; (...); Vilchez JJ
Article. 10.1111/ene.14630. 2021
Advances in the early diagnosis of amyotrophic lateral sclerosis.
Garcia-Casanova, Pilar H, Vazquez-Costa, Juan F
Article. 10.1080/14737175.2025.2471556. 2025
Amyloid brain-dedicated PET images can diagnose Alzheimer's pathology with Centiloid Scale.
Gandia-Ferrero MT; (...); Martí-Bonmatí L
Article. 10.1016/j.ejmp.2024.103345. 2024
Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community.
Vázquez-Costa JF; (...); Sevilla-Mantecón T
Article. 10.1016/j.nrl.2018.03.026. 2018
Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community.
Vazquez-Costa, J F; (...); Sevilla-Mantecon, T
Article. 10.1016/j.nrleng.2018.03.023. 2021
Angiotensin II Receptor Blockers Reduce Tau/ASS42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study.
Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo
Article. 10.3390/pharmaceutics15030924. 2023
Argon laser peripheral iridoplasty and anterior segment optical coherence tomography in the management of acute angle closure in the 21st century.
Placinta IA; (...); Vila-Arteaga J
Article. 10.1016/j.oftal.2018.03.004. 2018
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent, Joan; (...); Marti-Bonmati, Luis
Article. 10.1007/s10916-022-01836-w. 2022
Assessment of apolipoprotein E genotype for ß-amyloid status prediction.
Peña-Bautista C; (...); Chafer-Pericas, Consuelo
Article. 10.2174/1567205019666211223141524. 2021
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1007/s00415-023-11899-5. 2023
Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.clinbiochem.2019.07.008. 2019
Assessment of Lipid Peroxidation in Alzheimer's Disease Differential Diagnosis and Prognosis.
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox11030551. 2022
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia.
Álvarez-Sánchez L; (...); Cháfer-Pericás C
Article. 10.3390/ijms24021226. 2023
Assessment of Screening Approach in Early and Differential Alzheimer's Disease Diagnosis.
Ferré-González L; (...); Cháfer-Pericás C
Article. 10.3390/antiox10111662. 2021
Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo
Article. 10.1177/13872877241304995. 2024
Attitudes toward seeking professional help among patients with early Alzheimer's disease
Villarejo-Galende, A.; (...); Maurino, J.
Meeting Abstract. 2023
ATYPICAL HEALING IN A CASE WITH RETINAL PIGMENT EPITHELIUM APERTURES.
Molina-Pallete R; (...); Dolz-Marco R
Article. 10.1097/ICB.0000000000000789. 2018
Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.
Villarejo-Galende, Alberto; (...); Maurino, Jorge
Article. 10.1007/s40120-022-00367-3. 2022
Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis
Vazquez-Costa, JF; (...); Sevilla, T
Article. 10.1111/ane.12863. 2018
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions.
García-Lluch G; (...); Cháfer-Pericás C
Article. 10.14283/jpad.2024.16. 2024
Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1016/j.jns.2021.118062. 2021
Clinical and Magnetic Resonance Imaging features of a series of 11 Spanish patients who carry mutations in the BICD2 gene
Carrera, MF; (...); Sevilla, T
Meeting Abstract. 2018
Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies.
Muelas, Nuria; (...); Vilchez, Juan J
Article. 10.1007/s00415-024-12821-3. 2025
Clinical trials in pediatric ALS: a TRICALS feasibility study.
Kliest T; (...); Van Den Berg LH
Article. 10.1080/21678421.2021.2024856. 2022
Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer Disease.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1111/eci.13910. 2022
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox9080649. 2020
COGNITIVE FUNCTION FOLLOWING AN INTRACEREBRAL HEMORRHAGE ASSOCIATED WITH CEREBRAL AMYLOID ANGIOPATHY.
Gimenez, C; (...); Lago, A
Meeting Abstract. 2020
Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations
Lupo, V; (...); SEVILLA, T
Article. 10.1136/jmedgenet-2018-105650. 2018
Characterizing SOD1 mutations in Spain. The impact of genotype, age, and sex in the natural history of the disease.
Vazquez-Costa, Juan F.; (...); Garcia-Redondo, Alberto
Article. 10.1111/ene.15661. 2022
Charcot-Marie-Tooth disease due to MORC2 mutations in Spain
Sivera R; (...); Sevilla T
Article. 10.1111/ene.15001. 2021
Decreased spasticity in primary lateral sclerosis after botulinum toxin injection: A case report
Cea, AA; (...); Salazar, MG
Letter. 10.1016/j.nrl.2016.01.005. 2018
Defining Alzheimer's Disease through Proteomic CSF Profiling.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1021/acs.jproteome.4c00590. 2024
Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus)
Pitarch Castellano, I; (...); Vazquez-Costa, J. F.
Article. 10.1016/j.nrl.2021.07.008. 2022
Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus).
Pitarch Castellano I; (...); Vázquez-Costa JF
Practice Guideline. 10.1016/j.nrleng.2021.07.002. 2022
Depression and Suicide Risk in Mild Cognitive Impairment: The Role of Alzheimer's Disease Biomarkers
Ferrer-Cairols, Ines; (...); Salvador, Alicia
Article. 10.7334/psicothema2022.103. 2022
Descriptive analysis of the spinal muscular atrophy population treated with Nusinersen included in the CuidAME project
Sotoca Fernandez, J.; (...); Fernandez-Garcia, M.
Meeting Abstract. 10.1016/j.nmd.2024.07.462. 2024
Design and Validation of a Clinical Outcome Measure for Adolescents and Adult Patients with Spinal Muscular Atrophy: SMA Life Study Protocol
Rebollo, Pablo; (...); Vazquez-Costa, Juan F.
Article. 10.1007/s40120-023-00571-9. 2024
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study).
Madruga-Garrido M; (...); Maurino J
Article. 10.1007/s40120-020-00229-w. 2021
Diagnostic delay and pathway analysis in paediatric Charcot-Marie-Tooth disease
Argente-Escrig, H; (...); Mantecon, MTS
Meeting Abstract. 2019
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1212/NXG.0000000000200038. 2022
Discordant Amyloid Status Diagnosis in Alzheimer's Disease.
García-Vallés L; (...); Cháfer-Pericás C
Article. 10.3390/biomedicines10112880. 2022
Distal hereditary motor neuropathies: mutation spectrum and genotype-phenotype correlation.
Frasquet, Marina; (...); Lupo, Vincenzo
Article. 10.1111/ene.14700. 2021
Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to 'Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R' published in Vol. 24(3-4), pp. 311-316
Article. 10.1080/21678421.2023.2248199. 2024
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms241814151. 2023
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
Pena-Bautista, Carmen; (...); Cháfer-Pericás C
Article. 10.1038/s41598-020-73362-z. 2020
Effects of bilingualism on white matter atrophy in mild cognitive impairment: a diffusion tensor imaging study.
Marin-Marin L; (...); Ávila C
Article. 10.1111/ene.14135. 2020
Emotion recognition and baseline cortisol levels relationship in early Alzheimer Disease.
Ferrer-Cairols, I.; (...); Chafer-Pericas, C.
Article. 10.1016/j.biopsycho.2023.108511. 2023
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages.
Peña-Bautista C; (...); Chafer-Pericas, Consuelo
Article. 10.3390/biomedicines9121812. 2021
Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
Barceló MA; (...); Saez M
Article. 10.1038/s41598-021-85395-z. 2021
Facial Onset Sensory and Motor Neuronopathy New Cases, Cognitive Changes, and Pathophysiology
de Boer, EMJ; (...); van Es, MA
Review. 10.1212/CPJ.0000000000000834. 2021
Facial onset sensory and motor neuronopathy: a motor neuron disease with an oligogenic origin?
Vazquez-Costa, JF; (...); Sevilla, T
Article. 10.1080/21678421.2019.1582671. 2019
Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.
Álvarez-Sánchez L; (...); Pericás CC
Article. 10.2174/011570159X332930240925095423. 2024
Fatigue, pain, breathing, voice, fatigability, sleep, rest and vulnerability as meaningful outcomes in SMA care: the patients ' and caregivers' voice
Povedano, M.; (...); Rebollo, P.
Meeting Abstract. 10.1016/j.nmd.2022.07.209. 2022
Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Review. 10.1016/j.cca.2019.01.021. 2019
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
Moreno-Grau, S; (...); GR ACE Study Grp
Article. 10.1016/j.jalz.2019.06.4950. 2019
Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
Mazon, M; (...); Marti-Bonmati, L
Review. 10.3389/fnins.2018.00784. 2018
Imaging Biomarkers in Amyotrophic Lateral Sclerosis
Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis
Editorial Material. 10.1007/978-1-0716-1712-0_20. 2022
Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain
Garcia-Casanova, Pilar H.; (...); Vazquez-Costa, Juan F.
Article. 10.1111/ene.16465. 2024
Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.
Walter MC; (...); Servais L
Article. 10.3233/JND-200611. 2021
Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.
Baquero, Miguel; (...); Chafer-Pericas, Consuelo
Article. 10.3390/jcm13164735. 2024
Insights into phenotypic variability caused by GARS1 pathogenic variants.
Jiménez-Jiménez J; (...); Sivera R
Article. 10.1111/ene.16416. 2024
Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population.
Borrego-Hernandez, Daniel; (...); Garcia-Redondo, Alberto
Article. 10.3390/biomedicines12020356. 2024
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox9050407. 2020
La reserva cognitiva como factor modulador del impacto de la cirugía sobre la memoria visual y la denominación en pacientes con epilepsia del lóbulo temporal.
Cano-Lopez, I; (...); Gonzalez-Bono, E
Article. 10.33588/rn.7308.2021109. 2021
Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability
Armengol, Victor D.; (...); Roy, Bhaskar
Meeting Abstract. 2023
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.
Armengol, Victor D; (...); Roy, Bhaskar
Article. 10.1212/CPJ.0000000000200224. 2024
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
Pena-Bautista, Carmen; (...); Cháfer-Pericás C
Article. 10.3390/antiox10071043. 2021
Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.neuint.2019.104519. 2019
Lipid peroxidation in neurodegeneration.
Peña-Bautista C; (...); Cháfer-Pericás C
Review. 10.1016/j.cca.2019.07.037. 2019
Lipids as early and minimally invasive biomarkers for Alzheimer disease.
Casas-Fernandez, Esther; (...); Chafer-Pericas, Consuelo
Article. 10.2174/1570159X19666211102150955. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report.
Sansone VA; (...); Hagenacker T
Article. 10.3233/JND-200534. 2020
MEASURING THE EXPERIENCE OF LIVING WITH SPINAL MUSCULAR ATROPHY: THE ROLE OF THE SMA INDEPENDENCE SCALE
Vazquez, J. F.; (...); Madruga, M.
Meeting Abstract. 2022
Medical help-seeking intentions among patients with early Alzheimer's disease
Villarejo-Galende, Alberto; (...); Maurino, Jorge
Article. 10.3389/fpsyt.2023.1290002. 2023
Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.jpba.2019.113088. 2020
Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients.
Vázquez-Costa JF, Hervás D
Letter. 10.1111/ene.14780. 2021
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.
Peña-Bautista C; (...); Ferreira D
Article. 10.3389/fmolb.2023.1193458. 2023
Moral reasoning and moral conflict in patients of the amyotrophic lateral sclerosis - Frontotemporal dementia spectrum.
Serrano-Pastor, Lucas; (...); Vazquez-Costa, Juan F
Article. 10.1080/17470919.2020.1850521. 2020
Multimodal non-invasive imaging in choroidal rupture secondary to a firework explosion.
Placinta IA; (...); Cisneros-Lanuza Á
Case Reports. 10.1016/j.oftal.2018.06.009. 2019
Mutations in MME cause autosomal recessive late-onset CMT type-2 disease
Carrera, MF; (...); Sevilla, T
Meeting Abstract. 2018
Natural history data in adults with SMA
Letter. 10.1016/S1474-4422(20)30183-6. 2020
Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen
Andres-Benito, Pol; (...); Povedano, Monica
Article. 10.3390/ijms25073810. 2024
Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients
Pena-Bautista, C.; (...); Chafer-Pericas, C.
Article. 10.1016/j.exger.2019.05.007. 2019
New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers.
Forte, Anabel; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.cca.2024.117842. 2024
New insights into the genetic etiology of Alzheimer's disease and related dementias
Bellenguez, Celine; (...); CHARGE
Article. 10.1038/s41588-022-01024-z. 2022
New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study
Vazquez-Costa, JF; (...); Sevilla, T
Article. 10.1016/j.clinph.2018.09.014. 2018
New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.
Peña-Bautista C; (...); Chafer-Pericas, C
Article. 10.1038/s41598-019-50837-2. 2019
Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3233/JAD-215093. 2022
Nusinersen in adult patients with 5q spinal muscular atrophy: Amulticenter observational cohorts' study.
Vazquez-Costa, Juan F.; (...); Hervas, David
Article. 10.1111/ene.15501. 2022
Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment.
Díaz-Román M; (...); Gómez E
Article. 10.1093/sleep/zsaa133. 2021
Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Review. 10.2174/1570159X16666180926123722. 2019
Oxidative Damage of DNA as Early Marker of Alzheimer's Disease.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.3390/ijms20246136. 2019
Pediatric inherited peripheral neuropathy: a prospective study at a Spanish referral center
Argente-Escrig H; (...); Sevilla T
Article. 10.1002/acn3.51432. 2021
Person-centered Assessment in Early Alzheimers Disease (P1-1.Virtual)
Villarejo Galende, Alberto; (...); Maurino, Jorge
Meeting Abstract. 2022
Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study
Timmers, M; (...); Engelborghs, S
Article. 10.1186/s13195-018-0415-6. 2018
Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene
Frasquet, M; (...); Sevilla, T
Article. 10.1016/j.jns.2018.02.021. 2018
Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.cca.2019.10.023. 2020
Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1111/jnc.15183. 2020
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection
Pena-Bautista, C; (...); Chafer-Pericas, C
Article. 10.1016/j.freeradbiomed.2018.06.038. 2018
Plasma Lipidomics Approach in Early and Specific Alzheimer's Disease Diagnosis.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/jcm11175030. 2022
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.jprot.2019.04.008. 2019
Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease
Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo
Review. 10.1016/j.jns.2017.01.020. 2017
Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome
Vazquez-Costa, JF; (...); SEVILLA, T
Article. 10.3389/fnmol.2021.721047. 2021
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
López-Cuevas R; (...); Cháfer-Pericás C
Article. 10.1016/j.nrl.2020.07.026. 2020
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
Lopez-Cuevas, R; (...); Chafer-Pericas, C
Article. 10.1016/j.nrleng.2020.07.024. 2023
Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis
Rios-Diaz, J; (...); Martinez-Paya, JJ
Article. 10.1007/s00330-018-5943-8. 2019
Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of Alzheimer's and Parkinson's diseases.
Mayo, Sonia; (...); Chafer-Pericas, Consuelo
Review. 10.2174/1570159X19666201223154009. 2020
Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.
Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis
Article. 10.1016/j.bbr.2023.114844. 2024
Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms25105317. 2024
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease
Timmers, M; (...); Streffer, JR
Article. 10.1016/j.neurobiolaging.2019.03.016. 2019
Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers
Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.talanta.2018.03.002. 2018
Risdiplam in non-sitter patients aged 16years and older with 5q spinal muscular atrophy.
Nungo Garzon, Nancy Carolina; (...); Vazquez-Costa, Juan F
Article. 10.1002/mus.27804. 2023
Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis
Isabel Moreno-Gambin, Maria; (...); Vázquez-Costa JF
Article. 10.1007/s00415-021-10729-w. 2021
SONOELASTOGRAPHY FOR THE ASSESSMENT OF MUSCLE CHANGES IN AMYOTROPHIC LATERAL SCLEROSIS: RESULTS OF A PILOT STUDY
Martinez-Paya, JJ; (...); Vazquez-Costa, JF
Article. 10.1016/j.ultrasmedbio.2018.08.009. 2018
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
Schroth, Mary; (...); Vazquez-Costa, Juan F.
Article. 10.1212/CPJ.0000000000200310. 2024
STATISTICAL SOLUTIONS FOR ANALYTIC CHALLENGES IN REGISTRIES FOR HTA-PURPOSES
Fekete, I; (...); Volmer, T
Meeting Abstract. 2020
Stress and neurodegeneration.
Peña-Bautista C; (...); Cháfer-Pericás C
Review. 10.1016/j.cca.2020.01.019. 2020
The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis
Martinez-Paya, J. J.; (...); Vazquez-Costa, J. F.
Article. 10.1016/j.nrl.2022.01.008. 2024
The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis.
Martinez-Paya, J J; (...); Vazquez-Costa, J F
Article. 10.1016/j.nrleng.2024.07.003. 2024
The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers
Sanchez-Juan, P; (...); DEGESCO Consortium
Article. 10.3389/fnagi.2019.00327. 2019
The width of the third ventricle associates with cognition and behaviour in motor neuron disease
Vazquez-Costa, JF; (...); Sevilla, T
Article. 10.1111/ane.13022. 2019
Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
Pascual-Camps I; (...); Espana-Gregori E
Article. 10.1080/01676830.2018.1435694. 2018
Treatment of patients with spinal muscular atrophy 5q: Towards a new protocol.
Gomez-Andres, D., Martinez-Moreno, M., Vazquez-Costa, J. F.
Letter. 10.1016/j.nrl.2020.10.003. 2021
Treatment of patients with spinal muscular atrophy 5q: towards a new protocol.
Gómez-Andrés D, Martínez-Moreno M, Vázquez-Costa JF
Letter. 10.1016/j.nrleng.2020.10.005. 2021
Treatment of spinal muscular atrophy in European countries: A call to action
Vazquez-Costa, Juan F.; (...); Cattinari, Maria Grazia
Article. 10.1111/ene.15522. 2022
Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.
Veiga-Canuto D; (...); Aparici F
Article. 10.1111/ene.14586. 2021
Urinary symptoms in patients with amyotrophic lateral sclerosis.
Letter. 10.1016/j.nrl.2019.01.003. 2020
Use of Tachosil (R) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
Rahhal-Ortuno, M; (...); Cisneros-Lanuza, AL
Article. 10.4103/ijo.IJO_1573_18. 2019
Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.jpba.2018.11.043. 2019
Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study.
Vazquez-Costa, Juan F.; (...); Madruga-Garrido, Marcos
Article. 10.1007/s40120-022-00411-2. 2022
Validation of Neuromyotype: A smart keyboard for the evaluation of spinal muscular atrophy patients
Lizandra Cortes, P.; (...); Vazquez-Costa, J. F.
Article. 10.1016/j.nrl.2022.05.004. 2024
Validation of Neuromyotype: A smart keyboard for the evaluation of spinal muscular atrophy patients.
Cortes, P Lizandra; (...); Vázquez-Costa JF
Article. 10.1016/j.nrleng.2022.05.001. 2022
Zeus, the look through the anophthalmic cavity.
Placinta IA; (...); España-Gregori E
Article. 10.1016/j.oftal.2019.01.011. 2019